The Study of Bisphosphonate and Postmenopausal Hormone Treatment in Low Bone Mineral Density / 대한골다공증학회지
Journal of Korean Society of Osteoporosis
;
: 132-138, 2011.
Artículo
en Coreano
| WPRIM
| ID: wpr-760749
ABSTRACT
OBJECTIVES:
To evaluate the effect of postmenopausal hormone therapy alone or in combination with bisphosphonate on bone mineral density (BMD) in postmenopausal women.METHODS:
One hundred three women diagnosed with low BMD in postmenopausal women were included in this study. All patients were classified into two groups; oarl hormone therpy alone (Group I) or with alendronate (Group II), given for 12 months. Dual energy X-ray absorptiometry was used to measure BMD before and after 12 months of treatment.RESULTS:
In all groups, significant increase in bone density measurements were seen at 12 months of treatment. The BMD of lumbar spine more increased significantly in Group II than Group I.CONCLUSIONS:
Postmenopausal hormone therapy is effective in osteopenic and osteoporotic women. However, the combined treatment with hormone therapy and bisphophonate is more effective in postmenopausal women with low BMD.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Columna Vertebral
/
Menopausia
/
Absorciometría de Fotón
/
Densidad Ósea
/
Alendronato
Límite:
Femenino
/
Humanos
Idioma:
Coreano
Revista:
Journal of Korean Society of Osteoporosis
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS